Dr. Ebeling & Assoc. GmbH

Dr. Marcel Daas

Dr. Marcel Daas

works as a medical-scientific employee at Dr. Ebeling & Assoc. GmbH, a service provider for the health care industry specialising in medical science, medical affairs and pharmacovigilance. Since September 2023, he has been working there in the field of medical writing, in particular in the creation of “Biocompatibility Evaluation Reports” (BERs) in accordance with the new regulation (EU) 2017/745, MDR. He supports pharmaceutical companies in the creation of medical evaluations of individual case safety reports and their causality assessments in case of potential side effects. He also works in drug safety by conducting regular literature searches as part of a concept for GVP-compliant signal detection and continuous benefit-risk assessment.

He completed his studies at the Bonn-Rhein-Sieg University of Applied Sciences in Applied Biology and at the Rhineland-Palatinate Technical University of Kaiserslautern-Landau (formerly the Technical University of Kaiserslautern) in Molecular Cell Biology and Neurobiology. He then worked as a research associate at the University of Greenwich in the UK, where he completed his doctorate in neural stem cell research and human brain development in 2022.